Vicore Pharma Holding AB insider transactionsStockholm
LEI 549300KTNBPTZLF01130 · XSTO · SE · Business ID 556680-3804
Get alerts for Vicore Pharma Holding AB
12-month buy/sell summary
SEK 1,691,966.30 boughtNo sales
Open-market buys: 1Sales: 0Share awards: 0
Recent insider sentiment
No open-market buying or selling — last 90 days
Share-award batches are excluded from this read — they’re compensation, not conviction.
0
Open-market buys (90d)
0
Sales (90d)
0
Share awards (90d)
1
Active insiders (90d)
Transactions
| Date | Person | Transaction type | Volume | Price | Value | Source |
|---|---|---|---|---|---|---|
| 22.09.2026 | Elisabeth Björk — Board member | Other / unclassified | 44,132 | — | No cash value 44,132 shares | ↗ |
| 08.07.2026 | Yasir Al-Wakeel — Board member | Bought — open marketAcquisition | 363 | USD 13.79 | USD 5,005.73 | ↗ |
| 06.07.2026 | Hans Lennart Jeppsson — CFO | Bought — open marketAcquisition | 3 | USD 13.90 | USD 41.70 | ↗ |
| 06.07.2026 | Ahmed Mousa — CEO | Bought — open marketAcquisition | 670 | USD 14.90 | USD 9,983.00 | ↗ |
| 12.06.2026 | peter guenter — Board member | Bought — open marketAcquisition | 160,220 | SEK 10.56 | SEK 1,691,966.30 | ↗ |
Active insiders (90d)
Elisabeth Björk
Board member
44,132 shares
1 filing